This type of vaccine it is not expected to protect from infection acquisition, but rather to contain infection (i.e., low to undetectable plasma viral load and no CD4+ T cell loss), preventing progression to disease as well as virus transmission (Figure 1). This evidence concerns the gene CD4 and infection.